Bempikibart (ADX-914) is a fully humanised monoclonal antibody targeting IL-7Ralpha, capable of inhibiting IL-17 and TSLP (Thymic stromal lymphopoietin), and may be employed in studies of cutaneous inflammation and alopecia.
Purity:
95.00%
CAS Number:
[2622254-57-1]
Target:
IL Receptor|||Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted